News

Watkins-Conti Receives FDA Clearance for Yōni.Fit, a Breakthrough Device for Stress Urinary Incontinence

Watkins-Conti, a women’s health company dedicated to advancing pelvic health solutions, has achieved a significant milestone with the FDA 510(k) clearance for its device, Yōni.Fit Bladder Support. Designed and manufactured in the U.S. using 100% medical-grade silicone, Yōni.Fit represents a new approach to addressing SUI without resorting to surgery. The device, designed as a soft vaginal insert, effectively reduces urine leaks while…

What’s New in Femtech This Week? (May 16, 2024)

Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page. Highlights May Health raises $25M in Series A funding to advance Ovarian Rebalancing Therapy for PCOS. Mae secures oversubscribed seed funding round to tackle maternal health disparities. Backpack Healthcare secures $14M…

TiumBio Shares Positive Phase 2a Trial Results for Merigolix in Endometriosis Treatment Following $12M Funding Round

TiumBio, a clinical-stage biopharmaceutical company based in South Korea, recently unveiled encouraging findings from its Phase 2a clinical trial of Merigolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, aimed at alleviating moderate to severe endometriosis-associated pain. This announcement comes on the heels of a successful $12 million funding round, earmarked to advance the company’s clinical pipeline. The Phase 2a trial showcased promising…

Novo Nordisk Foundation, Wellcome & Gates Foundation Commit $300M to Advance Global Health Equity

The Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have joined forces to advance global health equity. This partnership, announced at the Novo Nordisk Foundation’s Global Science Summit in Denmark, involves a substantial commitment of $300 million over three years to support critical scientific research and development (R&D) aimed at addressing pressing global health challenges. The objective of this…

Acclinate Secures $7M in Series A Funding to Drive Health Equity Advancement

Acclinate, a company mobilizing diverse communities for improved healthcare access, has announced the successful closure of its $7 million Series A financing round. Led by Cencora Ventures, with participation from Labcorp and Latimer Ventures, this funding will support Acclinate’s efforts to expand its impact in the realm of clinical trial diversity and health equity. “This investment represents a pivotal moment for Acclinate…

Women’s health startups are reaching for the stars. Literally.

Women’s health startups are setting ambitious goals these days, and celebrities and their star power are increasingly part of the journey. Recently, I spoke with a founder of a U.S.-based femtech company who is in the midst of a Series B fundraising round. When asked about their plans for the funding, the founder mentioned their intent to onboard a celebrity advocate—a growing trend in the sector.…

Maternal Health Company Pacify Expands Its Doula-Led Maternity Care Services with Major Care Acquisition

In a strategic move to strengthen its presence in the maternity care landscape, Pacify, a maternity care solutions provider, has announced its acquisition of Major Care, a douola-led maternal wellness company. Both Pacify and Major Care share a dedication to providing maternity care services facilitated by doulas and empowered by technology. By joining forces, the aim is to elevate the accessibility and…

Gameto Announces New Data Demonstrating Clinical-Grade Manufacturing of In Vitro Maturation Solution Fertilo for Fertility Care

In a recent study, Gameto revealed promising findings regarding their investigational in vitro maturation (IVM) solution, Fertilo. Led by CEO and co-founder Dr. Dina Radenkovic, the biotech company showcased the intricate cellular engineering and manufacturing processes behind Fertilo. The novel solution contains engineered ovarian support cells (OSCs), aimed at maturing eggs outside the body. “This study is the first to demonstrate the…